Since its establishment, Yangzijiang Pharmaceutical has aimed to make the pharmaceutical industry bigger and stronger and move towards an international enterprise. It has continuously accelerated the pace of scientific and technological innovation and independent brand building to build core competitiveness. The comprehensive economic strength of the company has been improved. Improve quickly. Since 1996, the company's various economic and technical indicators have ranked first in Jiangsu's pharmaceutical industry for more than 10 consecutive years. Since 1997, it has been among the top five in the national pharmaceutical industry for many years. From 2004 to 2006, the group's sales and profit and tax indicators both ranked first among its peers in the country. It was listed among the "Top 500 Largest Enterprise Groups in China" and the "Top 500 National Taxpayers", becoming the "new number one" among Chinese pharmaceutical companies. The company's "Huyou" trademark won the title of China's Well-known Trademark, and passed the three international certifications of ISO14001, OHSAS18001 and ISO9001.

In the development of the enterprise, Yangzijiang Pharmaceutical Group adheres to the development path of "revitalizing the enterprise through science and technology" and "strengthening the enterprise through science and technology", in accordance with the "three highs and one special" (high-tech content, high added value, high With a new product development strategy (unique market capacity and efficacy), the annual expenditure on technological innovation and development accounts for more than 5% of sales revenue. In addition to independent research and development, we also cooperate extensively with well-known domestic academicians, experts, and major university research institutions through industry-university-research cooperation, and cooperate with overseas senior scientific researchers to establish joint laboratories for joint development and research. The company has established a "postdoctoral scientific research workstation" and a "national technology center", and has transferred its scientific research tentacles to big cities, and has successively prepared to establish scientific research centers in subsidiaries such as Beijing, Shanghai, Nanjing, Chengdu, and Guangzhou. Aiming to promote breakthroughs and integrated innovation in key technologies for the modernization of traditional Chinese medicine, with the approval of the National Development and Reform Commission, in 2003, Yangzijiang established the "Nanjing Hailing National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology" in conjunction with five domestic universities and research institutes. Since 2006, Yangzijiang has also been listed as a "National Innovative Pilot Enterprise" and "National Key Laboratory of New Pharmaceutical Preparation Technology" by the Ministry of Science and Technology. As an important part of China (Taizhou) Medical City, the "Jiangsu (Taizhou) New Drug Research Institute" with a total investment of 183 million yuan, prepared by Yangzijiang Pharmaceutical Group, has been included in the provincial "Eleventh Five-Year Plan" major scientific and technological infrastructure construction projects. . By integrating scientific research resources, it is planned to build four major R&D centers: Chemical Drug R&D Technology Center, Pharmaceutical Preparation Engineering Technology Research Center, Traditional Chinese Medicine Manufacturing Process Engineering Research Center and Biological Drug R&D Technology Center, and establish supporting scientific and technological achievement transformation centers and industries. chemical base.